FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 — The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives …
WEBAug 23, 2021 — COMIRNATY is the first COVID-19 vaccine to be granted FDA approval ; Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose; More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020
FDA Approves Updated COVID Vaccines From Pfizer And …
WEBAug 22, 2024 — Individuals 12 and older can receive a single dose of Comirnaty or Spikevax. Additional doses are authorized for certain immunocompromised individuals ages 6 months through 11 years, as described...
Pfizer and BioNTech Provide Update on mRNA-based …
WEBAug 16, 2024 — Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received mRNA COVID-19 vaccines, including COMIRNATY and Pfizer-BioNTech COVID-19 vaccines.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 — Approval of Comirnaty (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, and a change to a single dose for individuals 12 years of age and older.
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization …
WEBAug 22, 2024 — This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162b2 mRNA vaccine program, and the Pfizer-BioNTech COVID-19 Vaccine, also known as COMIRNATY ® (COVID-19 Vaccine, mRNA) (BNT162b2) including an approval in the U.S ...
FDA Approves First COVID-19 Vaccine
WEBThe vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years...
Study confirms effectiveness of the new omicron booster
WEB3 hours ago — Currently, the virus variant omicron JN.1 and its sub-lineages KP.2 and KP.3 are predominant. Since August this year, the vaccine named Comirnaty omicron JN.1 from BioNTech/Pfizer, which has been ...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 — Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 trial evaluating the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-19 ...
Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations
WEBAug 28, 2024 — FDA approved the updated 2024-2025 formula of COMIRNATY on August 22, 2024. FDA also granted emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine 2024-2025 Formula on August 22, 2024.
- Some results have been removed